rs200392453

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_001378609.3(OTOGL):ā€‹c.3566A>Gā€‹(p.Gln1189Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000683 in 1,613,040 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00028 ( 0 hom., cov: 32)
Exomes š‘“: 0.00072 ( 1 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

3
10
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 8.86
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
OTOGLNM_001378609.3 linkuse as main transcriptc.3566A>G p.Gln1189Arg missense_variant 31/59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkuse as main transcriptc.3566A>G p.Gln1189Arg missense_variant 31/595 NM_001378609.3 ENSP00000447211 P1
OTOGLENST00000646859.1 linkuse as main transcriptc.3431A>G p.Gln1144Arg missense_variant 35/63 ENSP00000496036

Frequencies

GnomAD3 genomes
AF:
0.000283
AC:
43
AN:
152180
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000515
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000227
AC:
56
AN:
246484
Hom.:
0
AF XY:
0.000202
AC XY:
27
AN XY:
133870
show subpopulations
Gnomad AFR exome
AF:
0.000321
Gnomad AMR exome
AF:
0.0000581
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000426
Gnomad OTH exome
AF:
0.000332
GnomAD4 exome
AF:
0.000725
AC:
1059
AN:
1460742
Hom.:
1
Cov.:
31
AF XY:
0.000711
AC XY:
517
AN XY:
726696
show subpopulations
Gnomad4 AFR exome
AF:
0.000150
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000934
Gnomad4 OTH exome
AF:
0.000265
GnomAD4 genome
AF:
0.000282
AC:
43
AN:
152298
Hom.:
0
Cov.:
32
AF XY:
0.000269
AC XY:
20
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000515
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000491
Hom.:
0
Bravo
AF:
0.000306
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000459
AC:
2
ESP6500EA
AF:
0.000467
AC:
4
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000546
EpiControl
AF:
0.000594

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:4
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 16, 2020The p.Gln1180Arg variant in OTOGL has been previously reported by our laboratory in 1 individual with hearing loss; however, a variant affecting the remaining copy of OTOGL was not identified. It has been identified in 0.04% (56/125812) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org/). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Gln1180Arg variant is uncertain. ACMG/AMP Criteria applied: PP3, PM2_Supporting. -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMar 08, 2021This variant is present in population databases (rs200392453, ExAC 0.03%). This sequence change replaces glutamine with arginine at codon 1180 of the OTOGL protein (p.Gln1180Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. This variant has not been reported in the literature in individuals with OTOGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 504850). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2023OTOGL: PM2, BP4 -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxOct 07, 2021In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 01, 2022The c.3539A>G (p.Q1180R) alteration is located in exon 30 (coding exon 30) of the OTOGL gene. This alteration results from a A to G substitution at nucleotide position 3539, causing the glutamine (Q) at amino acid position 1180 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal recessive nonsyndromic hearing loss 84B Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsMar 11, 2019This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.085
D
BayesDel_noAF
Pathogenic
0.24
CADD
Uncertain
24
DANN
Uncertain
1.0
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.78
T;.;T
M_CAP
Uncertain
0.090
D
MetaRNN
Uncertain
0.58
D;D;D
MetaSVM
Uncertain
-0.069
T
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-3.5
.;.;D
REVEL
Pathogenic
0.79
Sift
Uncertain
0.0090
.;.;D
Sift4G
Uncertain
0.026
.;.;D
Vest4
0.66
MVP
0.71
MPC
0.19
ClinPred
0.22
T
GERP RS
5.8
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200392453; hg19: chr12-80707371; API